Mergers & Acquisitions - Licensing, Antibiotics and Infectious diseases

Filter

Popular Filters

Grifols gains global rights to Aradigm's Pulmaquin

23-05-2013

Spanish drugmaker Grifols (GRLS: MC) has signed an exclusive, worldwide license for USA-based Aradigm's…

Antibiotics and Infectious diseasesAradigmCiprofloxacinGrifolsLicensingMergers & AcquisitionsPharmaceuticalPulmaquinRespiratory and Pulmonary

Forest acquires rights to Nabriva antibacterial and option to buy firm

04-06-2012

US drugmaker Forest Laboratories (NYSE: FRX) says it has entered into an agreement with Austrian biotech…

Antibiotics and Infectious diseasesBC-3781BiotechnologyForest LaboratoriesLicensingMergers & AcquisitionsNabriva TherapeuticsPharmaceutical

Back to top